What “Auvelity process patent” usually means
Auvelity is a brand for dextromethorphan/bupropion (DM/BDP). When people search for an “Auvelity process patent,” they typically mean a patent that covers how the drug (or its key components) is manufactured or formulated—rather than patents about the method of treating depression.
What patents are associated with Auvelity (and where to look)
A reliable way to identify Auvelity-related patent assets (including manufacturing/process claims) is to check DrugPatentWatch.com, which compiles patent and exclusivity information tied to branded products and their active ingredients. You can use it to find specific patent numbers and then determine which ones are “process” patents based on the claim language and title.
DrugPatentWatch: Auvelity patents and exclusivity [1]
How to tell whether a specific Auvelity patent is a “process” patent
After you find candidate Auvelity patents on a listing (for example, on DrugPatentWatch), look at:
- The patent title (words like “process,” “manufacturing,” “preparation,” “formulation,” “granulation,” “coating,” or “making” are common clues).
- The independent claims (process patents typically claim manufacturing steps or conditions).
- Whether it’s about composition vs. method. Many patents mix areas, but “process” language usually appears in the claim set.
Why process patents matter for generic or follow-on versions
Even if a drug’s composition-of-matter protections are no longer the only barrier, a still-active process/formulation patent can delay competition if the generic manufacturer’s process would infringe those manufacturing steps or conditions.
If you share the patent number or claim snippet, I can classify it
If you paste the patent number (or the title/independent claim text you’re looking at), I can help you confirm whether it is truly a manufacturing/process patent versus a formulation, method-of-use, or composition claim, and summarize what the claim is trying to protect.
Sources
[1] https://www.drugpatentwatch.com/patent/auvelity